Association of Time to Kidney Transplantation With Graft Failure Among US Patients With End-Stage Renal Disease Due to Lupus Nephritis

被引:36
|
作者
Plantinga, Laura C. [1 ,2 ]
Patzer, Rachel E. [3 ,4 ]
Drenkard, Cristina [4 ]
Kramer, Michael R. [1 ]
Klein, Mitchel [1 ]
Lim, S. Sam [4 ]
McClellan, William M. [1 ]
Pastan, Stephen O. [3 ,4 ]
机构
[1] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
[2] Emory Univ, Laney Grad Sch, Atlanta, GA 30322 USA
[3] Emory Healthcare, Emory Transplant Ctr, Atlanta, GA USA
[4] Emory Univ, Sch Med, Atlanta, GA 30322 USA
关键词
HEALTH DISPARITIES; OUTCOMES; RECIPIENTS; MORTALITY; DIALYSIS; ACCESS; GUIDELINES;
D O I
10.1002/acr.22482
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveProviders recommend waiting to transplant patients with end-stage renal disease (ESRD) secondary to lupus nephritis (LN), to allow for quiescence of systemic lupus erythematosus (SLE)-related immune activity. However, these recommendations are not standardized, and we sought to examine whether duration of time to transplant was associated with risk of graft failure in US LN-ESRD patients. MethodsUsing national ESRD surveillance data (United States Renal Data System), we identified 4,743 US patients with LN-ESRD who received a first transplant on or after January 1, 2000 (followup through September 30, 2011). The association of wait time (time from ESRD start to transplant) with graft failure was assessed with Cox proportional hazards models, with splines of the exposure to allow for nonlinearity of the association and with adjustment for potential confounding by demographic, clinical, and transplant factors. ResultsWhite LN-ESRD patients who were transplanted later (versus at <3 months receiving dialysis) were at increased risk of graft failure (3-12 months: adjusted hazard ratio [HR] 1.23, 95% confidence interval [95% CI] 0.93-1.63; 12-24 months: adjusted HR 1.37, 95% CI 0.92-2.06; 24-36 months: adjusted HR 1.34, 95% CI 0.92-1.97; and >36 months: adjusted HR 1.98, 95% CI 1.31-2.99). However, no such association was seen among African American recipients (3-12 months: adjusted HR 1.07, 95% CI 0.79-1.45; 12-24 months: adjusted HR 1.01, 95% CI 0.64-1.60; 24-36 months: adjusted HR 0.78, 95% CI 0.51-1.18; and >36 months: adjusted HR 0.74, 95% CI 0.48-1.13). ConclusionWhile future studies are needed to examine the potential confounding effect of clinically recognized SLE activity on the observed associations, these results suggest that longer wait times to transplant may be associated with equivalent or worse, not better, graft outcomes among LN-ESRD patients.
引用
收藏
页码:571 / 581
页数:11
相关论文
共 50 条
  • [31] Lupus Nephritis in Males: Clinical Features, Course, and Prognostic Factors for End-Stage Renal Disease
    Urrestaraz, Andres
    Otatti, Gabriela
    Silvarino, Ricardo
    Garau, Mariela
    Coitino, Ruben
    Alvarez, Asuncion
    Gonzalez, Esther
    Gadola, Liliana
    Praga, Manuel
    Noboa, Oscar
    KIDNEY INTERNATIONAL REPORTS, 2017, 2 (05): : 905 - 912
  • [32] Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease
    Meier-Kriesche, HU
    Schold, JD
    Srinivas, TR
    Reed, A
    Kaplan, B
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (10) : 1662 - 1668
  • [33] Factors Influencing Disease Recurrence and Graft Survival in Patients who Developed End-Stage Renal Disease Due to Focal Segmental Glomerulosclerosis and Underwent Renal Transplantation
    Yilmaz, Vural Taner
    Kocak, Huseyin
    Cetinkaya, Ramazan
    Ulger, Burak Veli
    Suleymanlar, Gultekin
    INTERNATIONAL SURGERY, 2021, 105 (1-3) : 366 - 373
  • [34] End-stage renal disease in lupus: Disease activity, dialysis, and the outcome of transplantation
    Stone, JH
    LUPUS, 1998, 7 (09) : 654 - 659
  • [35] Bariatric surgery among patients with end-stage kidney disease: improving access to transplantation comment
    Montgomery, John R.
    Ghaferi, Amir A.
    Waits, Seth A.
    SURGERY FOR OBESITY AND RELATED DISEASES, 2020, 16 (01) : 14 - 16
  • [36] End-stage renal disease after liver transplantation in patients with pre-transplant chronic kidney disease
    Bahirwani, Ranjeeta
    Forde, Kimberly A.
    Mu, Yifei
    Lin, Fred
    Reese, Peter
    Goldberg, David
    Abt, Peter
    Reddy, K. Rajender
    Levine, Matthew
    CLINICAL TRANSPLANTATION, 2014, 28 (02) : 205 - 210
  • [37] Frailty Prevalence in Younger End-Stage Kidney Disease Patients Undergoing Dialysis and Transplantation
    Chu, Nadia M.
    Chen, Xiaomeng
    Norman, Silas P.
    Fitzpatrick, Jessica
    Sozio, Stephen M.
    Jaar, Bernard G.
    Frey, Alena
    Estrella, Michelle M.
    Xue, Qian-Li
    Parekh, Rulan S.
    Segev, Dorry L.
    McAdams-DeMarco, Mara A.
    AMERICAN JOURNAL OF NEPHROLOGY, 2020, 51 (07) : 501 - 510
  • [38] Renal Transplantation and Survival Among Patients With Lupus Nephritis A Cohort Study
    Jorge, April
    Wallace, Zachary S.
    Lu, Na
    Zhang, Yuqing
    Choi, Hyon K.
    ANNALS OF INTERNAL MEDICINE, 2019, 170 (04) : 240 - +
  • [39] Goal-Directed Heart Failure Care in Patients With Chronic Kidney Disease and End-Stage Renal Disease
    McCullough, Peter A.
    Afzal, Aasim
    Kale, Parag
    JACC-HEART FAILURE, 2016, 4 (08) : 662 - 663
  • [40] Bilateral Nephrectomy in Patients with Autosomal Dominant Polycystic Kidney Disease and End-Stage Chronic Renal Failure
    Lubennikov, Alexander E.
    Petrovskii, Nicolay, V
    Krupinov, German E.
    Shilov, Evgeniy M.
    Trushkin, Roman N.
    Kotenko, Oleg N.
    Glybochko, Petr, V
    NEPHRON, 2021, 145 (02) : 164 - 170